United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - metformin hydrochloride; saxagliptin hydrochloride - tablet - 850mg ; 2.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - metformin hydrochloride; saxagliptin hydrochloride - tablet - 1gram ; 2.5mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 2.79mg eqv saxagliptin - tablet, film coated, extended release - 1000.0 mg - metformin hydrochloride + 0.5% magnesium stearate 1000.0 mg; saxagliptin hydrochloride anhydrous 2.79mg eqv saxagliptin 2.5mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin - tablet, film coated, extended release - 1000mg - metformin hydrochloride + 0.5% magnesium stearate 1000mg; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin 5.0mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin - tablet, film coated, extended release - 500mg - metformin hydrochloride + 0.5% magnesium stearate 500mg; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin 5.0mg

European Union - English - EMA (European Medicines Agency)

astrazeneca ab  - metformin hydrochloride, saxagliptin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - komboglyze is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type-2 diabetes mellitus inadequately controlled on their maximally tolerated dose of metformin alone or those already being treated with the combination of saxagliptin and metformin as separate tablets.komboglyze is also indicated in combination with insulin (i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type-2 diabetes mellitus when insulin and metformin alone do not provide adequate glycaemic control.

Canada - English - Health Canada

astrazeneca canada inc - saxagliptin (saxagliptin hydrochloride); metformin hydrochloride - tablet - 2.5mg; 500mg - saxagliptin (saxagliptin hydrochloride) 2.5mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

astrazeneca canada inc - saxagliptin (saxagliptin hydrochloride); metformin hydrochloride - tablet - 2.5mg; 850mg - saxagliptin (saxagliptin hydrochloride) 2.5mg; metformin hydrochloride 850mg - biguanides

Canada - English - Health Canada

astrazeneca canada inc - saxagliptin (saxagliptin hydrochloride); metformin hydrochloride - tablet - 2.5mg; 1000mg - saxagliptin (saxagliptin hydrochloride) 2.5mg; metformin hydrochloride 1000mg - biguanides

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - metformin hcl 1000 mg, saxagliptin 2.5 mg - 1000 mg, 2.5 mg